←
Prof Ananya💙 @achoud72.bsky.social11,763 posts
Prof Ananya💙 @achoud72.bsky.social avatar

Prof Ananya💙 @achoud72.bsky.social

@achoud72

NHS consultant no private work. Equality, liberty and justice, Chair in Clinical Oncology, Christie & University of Manchester, EIC BMJ Oncology. Own views

◷ Joined July 2015▧ 1,005 Photos and videos
Melvin LK CHUA | FRCR, PhD, FASCO avatar
⟳ Prof Ananya💙 @achoud72.bsky.social retweeted
Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua·Nov 10

Not often do we publish 2 back to back guidelines on #NasopharyngealCarcinoma in @JCO_ASCO Was a pleasure leading this monumental effort with @BrigetteMa2 @ASCO CSCO 💪🏻💪🏻💪🏻 Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JCO…

OncoAlert avatar
⟳ Prof Ananya💙 @achoud72.bsky.social retweeted
OncoAlert@OncoAlert·Nov 8

Join OncoAlert and our collaborators at @mirrorsmed for the 2026 Global Forum in GU Oncology. REGISTER HERE: gu-global-forum.org/?utm_sou… Here is our friend, Dr. Philippe BARTHÉLÉMY 🇫🇷, to tell us more about this great forum! 📅 December 2–5, 2026 📍 Amsterdam, Netherlands This is an excellent opportunity to learn how to translate the latest advances in oncology into your clinical practice. #Prosca26 #BLADDR25 #RENALC26 @BertrandTOMBAL @Ric_Campi @achoud72 @bkonety @lisapic @Achard_Verane @MichvdHeijden @roodvdb @Zondervan_AUMC @karolien_goffin

0:55
Prof Ananya💙 @achoud72.bsky.social avatar
Prof Ananya💙 @achoud72.bsky.social@achoud72·Nov 3

🚨Come & join us in our exciting programme of Radiotherapy-related research @TheChristieNHS . Lead radiographer-led research. Get in touch @MCRCnews @ESTRO_RT @SCoRMembers @RT_physics #RTT bmj.com/healthcareers/job/86…

BMJ Oncology avatar
⟳ Prof Ananya💙 @achoud72.bsky.social retweeted
BMJ Oncology@BMJOncology·Oct 30

AI pathology may speed patient selection and make cancer-trial assessments more consistent. This review explains what it takes to reach patients: reliable tissue data, connected lab systems and validation across hospitals. bmjoncology.bmj.com/content/…

Post attachment
BMJ Oncology avatar
⟳ Prof Ananya💙 @achoud72.bsky.social retweeted
BMJ Oncology@BMJOncology·Oct 26

Could cancer patients safely receive fewer doses of immunotherapy? A BMJ Oncology review explores ways to ease the burden on patients and health services while preserving treatment benefit. bmjoncology.bmj.com/content/…

Post attachment
Gerry Hanna avatar
⟳ Prof Ananya💙 @achoud72.bsky.social retweeted
Gerry Hanna@gerryhanna·Oct 25

Presenting the UK’s SARON study Dr @fifimcdrmh to a full hall at #ESMO26 In patients with de novo oligometastatic mutation driver negative #NSCLC , consolidation radiotherapy to the primary and metastases improved PFS but no OS No significant difference in QOL or AEs Huge thanks to all the patients and trialists involved

Post attachmentPost attachmentPost attachmentPost attachment
NonsparseOncologist avatar
⟳ Prof Ananya💙 @achoud72.bsky.social retweeted
NonsparseOncologist@5_utr·Oct 10

Every cancer organ gets the same sequence: surgery is the standard, then trials show you often don't need it, then surgery becomes the salvage. Breast, larynx, limb, rectum, esophagus, mesothelioma. Bladder is next. Patients want their organs. 🧵

Manchester Cancer Research Centre avatar
⟳ Prof Ananya💙 @achoud72.bsky.social retweeted
Manchester Cancer Research Centre@MCRCnews·Oct 5

Applications are now open for our 2027 entry Cancer Research UK (CRUK)-funded PhD opportunities! 🧪 👩‍🔬 Interested in applying for a Clinical or Non-Clinical PhD? Explore our available projects: crukcentre.manchester.ac.uk/… 📆 Deadline: Monday 23rd November 2026